Literature DB >> 33875758

Therapeutic effects and outcomes of rescue high-frequency oscillatory ventilation for premature infants with severe refractory respiratory failure.

Jen-Fu Hsu1,2, Mei-Chin Yang3,4, Shih-Ming Chu1,2, Lan-Yan Yang5, Ming-Chou Chiang1,2, Mei-Yin Lai1,2, Hsuan-Rong Huang1,2, Yu-Bin Pan5, Ren-Huei Fu1,2, Ming-Horng Tsai6,7.   

Abstract

Despite wide application of high frequency oscillatory ventilation (HFOV) in neonates with respiratory distress, little has been reported about its rescue use in preterm infants. We aimed to evaluate the therapeutic effects of HFOV in preterm neonates with refractory respiratory failure and investigate the independent risk factors of in-hospital mortality. We retrospectively analyzed data collected prospectively (January 2011-December 2018) in four neonatal intensive care units of two tertiary-level medical centers in Taiwan. All premature infants (gestational age 24-34 weeks) receiving HFOV as rescue therapy for refractory respiratory failure were included. A total of 668 preterm neonates with refractory respiratory failure were enrolled. The median (IQR) gestational age and birth weight were 27.3 (25.3-31.0) weeks and 915.0 (710.0-1380.0) g, respectively. Pre-HFOV use of cardiac inotropic agents and inhaled nitric oxide were 70.5% and 23.4%, respectively. The oxygenation index (OI), FiO2, and AaDO2 were markedly increased after HFOV initiation (all p < 0.001), and can be decreased within 24-48 h (all p < 0.001) after use of HFOV. 375 (56.1%) patients had a good response to HFOV within 3 days. The final in-hospital mortality rate was 34.7%. No association was found between specific primary pulmonary disease and survival in multivariate analysis. We found preterm neonates with gestational age < 28 weeks, occurrences of sepsis, severe hypotension, multiple organ dysfunctions, initial higher severity of respiratory failure and response to HFOV within the first 72 h were independently associated with final in-hospital mortality. The mortality rate of preterm neonates with severe respiratory failure remains high after rescue HFOV treatment. Aggressive therapeutic interventions to treat sepsis and prevent organ dysfunctions are the suggested strategies to optimize outcomes.

Entities:  

Year:  2021        PMID: 33875758     DOI: 10.1038/s41598-021-88231-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  38 in total

1.  High-frequency oscillatory ventilation with volume guarantee: a single-centre experience.

Authors:  Gusztav Belteki; Colin J Morley
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2018-09-14       Impact factor: 5.747

2.  Changes in lung volume and ventilation during lung recruitment in high-frequency ventilated preterm infants with respiratory distress syndrome.

Authors:  Martijn Miedema; Frans H de Jongh; Inez Frerichs; Mariëtte B van Veenendaal; Anton H van Kaam
Journal:  J Pediatr       Date:  2011-03-17       Impact factor: 4.406

3.  Outcome of Preterm Neonates with a Birth Weight <1,500 g with Severe Hypoxemic Respiratory Failure Rescued by Inhaled Nitric Oxide Therapy and High-Frequency Oscillatory Ventilation.

Authors:  Atoosa Golfar; Jagmeet Bhogal; Barbara Kamstra; Ann Hudson-Mason; Mosarrat Qureshi; Georg M Schmölzer; Po-Yin Cheung
Journal:  Neonatology       Date:  2017-07-14       Impact factor: 4.035

4.  Relationship between Mean Airways Pressure, Lung Mechanics, and Right Ventricular Output during High-Frequency Oscillatory Ventilation in Infants.

Authors:  Emanuela Zannin; Daniela Doni; Maria Luisa Ventura; Tiziana Fedeli; Camilla Rigotti; Raffaele L Dellacá; Paolo E Tagliabue
Journal:  J Pediatr       Date:  2016-10-10       Impact factor: 4.406

5.  Determination of Lung Volume and Hemodynamic Changes During High-Frequency Ventilation Recruitment in Preterm Neonates With Respiratory Distress Syndrome.

Authors:  Milena Tana; Graeme R Polglase; Francesco Cota; Chiara Tirone; Claudia Aurilia; Alessandra Lio; Cinzia Ricci; Costantino Romagnoli; Giovanni Vento
Journal:  Crit Care Med       Date:  2015-08       Impact factor: 7.598

6.  Inhaled prostacyclin and high-frequency oscillatory ventilation in a premature infant with respiratory syncytial virus-associated respiratory failure.

Authors:  Manoj Gupta; Stephen Guertin; Steve Martin; Said Omar
Journal:  Pediatrics       Date:  2012-07-02       Impact factor: 7.124

7.  Adapted ECMO criteria for newborns with persistent pulmonary hypertension after inhaled nitric oxide and/or high-frequency oscillatory ventilation.

Authors:  Saskia van Berkel; Mathijs Binkhorst; Arno F J van Heijst; Marc H W A Wijnen; Kian D Liem
Journal:  Intensive Care Med       Date:  2013-04-12       Impact factor: 17.440

8.  The VICI-trial: high frequency oscillation versus conventional mechanical ventilation in newborns with congenital diaphragmatic hernia: an international multicentre randomized controlled trial.

Authors:  Lieke van den Hout; Dick Tibboel; Sanne Vijfhuize; Harma te Beest; Wim Hop; Irwin Reiss
Journal:  BMC Pediatr       Date:  2011-11-02       Impact factor: 2.125

9.  Gas exchange mechanisms in preterm infants on HFOV - a computational approach.

Authors:  Christian J Roth; Kai M Förster; Anne Hilgendorff; Birgit Ertl-Wagner; Wolfgang A Wall; Andreas W Flemmer
Journal:  Sci Rep       Date:  2018-08-29       Impact factor: 4.379

10.  Late outcomes of a randomized trial of high-frequency oscillation in neonates.

Authors:  Sanja Zivanovic; Janet Peacock; Mireia Alcazar-Paris; Jessica W Lo; Alan Lunt; Neil Marlow; Sandy Calvert; Anne Greenough
Journal:  N Engl J Med       Date:  2014-03-20       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.